← Medpal AI

What podcasts say about Medpal AI

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Medpal AI

10 statements · 9 negative · 1 neutral

  1. Medpal is worth substantially less than its £53 million market capitalization.

    “I don't think it's worth anywhere near the £53 million market cap personally”

    Listen at 12:21

    Open the episode · Morning Movers
  2. Medpal’s online weight-loss medication and prescription business has very low margins.

    “it's selling weight loss medications and things online and dispensing prescriptions, which is very low margin”

    Listen at 12:25

    Open the episode · Morning Movers
  3. Paul sees little investment attraction in MedPal AI.

    “I don't see the attraction at all here for Med-Pal AI, I'm afraid.”

    Listen at 22:54

    Open the episode · Paul's Podcast - Fri 3 July 2026
  4. MedPal AI lacks investment appeal because online prescription dispensing has low margins.

    “I don't see the attraction at all here for Med-Pal AI”

    Listen at 22:54

    Open the episode · Paul's Podcast - Fri 3 July 2026
  5. MedPal AI is an acquisitive startup.

    “it is, you know, very much an acquisitive startup.”

    Listen at 23:03

    Open the episode · Paul's Podcast - Fri 3 July 2026
  6. MedPal AI’s share-price rise appears unjustified by its announcement.

    “I think this is a bit of a spurious rise”

    Listen at 24:52

    Open the episode · Paul's Podcast - Fri 12 June 2026
  7. MedPal AI and comparable online pharmacies may become money-losing businesses.

    “they're probably just going to be money pits”

    Listen at 26:32

    Open the episode · Paul's Podcast - Fri 12 June 2026
  8. MedPal AI currently lacks a convincing competitive advantage.

    “right now Medpal AI is not convincing at all, and I don't see what its USP is.”

    Listen at 27:23

    Open the episode · Paul's Podcast - Fri 12 June 2026
  9. MedPal AI currently lacks a convincing competitive advantage.

    “Medpal AI is not convincing at all, and I don't see what its USP is”

    Listen at 27:23

    Open the episode · Paul's Podcast - Fri 12 June 2026
  10. MedPal AI is substantially overvalued for a startup.

    “Medpal AI is still selling off. It's just stupidly overpriced really for a startup, I think.”

    Listen at 30:00

    Open the episode · Paul's Podcast - Fri 13 Mar 2026

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Medpal AI: what podcasts say · PodLume